


Searching News Database: Teijin Limited
HSMN NewsFeed - 14 Feb 2018
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
HSMN NewsFeed - 28 Apr 2017
Teijin to Withdraw from U.S. Home Health Care Business to Complete Business Restructuring
Teijin to Withdraw from U.S. Home Health Care Business to Complete Business Restructuring
HSMN NewsFeed - 2 Oct 2006
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
